Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemically Programmable and Switchable CAR‐T Therapy
Junpeng Qi, Kohei Tsuji, David Hymel, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 29, pp. 12178-12185
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 486
Nanomaterials for T-cell cancer immunotherapy
Ningqiang Gong, Neil C. Sheppard, Margaret M. Billingsley, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 1, pp. 25-36
Closed Access | Times Cited: 246
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody–drug conjugates
Min Sun Kang, Theresa Wai See Kong, Yi Xin Joycelyn Khoo, et al.
Chemical Science (2021) Vol. 12, Iss. 41, pp. 13613-13647
Open Access | Times Cited: 83
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 11
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
Piotr Celichowski, Marcello Turi, Sandra Charvátová, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy
Nathanael J. Bangayan, Liang Wang, Giselle Burton Sojo, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 47
Open Access | Times Cited: 18
Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches
Yanjun Zheng, Kutty Selva Nandakumar, Kui Cheng
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 14, pp. 9577-9591
Closed Access | Times Cited: 34
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
Marta Włodarczyk, Beata Pyrzyńska
Cancers (2022) Vol. 15, Iss. 1, pp. 117-117
Open Access | Times Cited: 26
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
Prameela Kandra, Rajender Nandigama, Bastian Eul, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
ROR1-targeting switchable CAR-T cells for cancer therapy
Haiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Oncogene (2022) Vol. 41, Iss. 34, pp. 4104-4114
Open Access | Times Cited: 23
Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy
Qiang Zhang, Limei Wu, Yue Zhang, et al.
ACS Central Science (2024)
Open Access | Times Cited: 5
In vivo manufacture and manipulation of CAR-T cells for better druggability
Rui Hou, Xiaoxue Zhang, Xu Wang, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1075-1093
Closed Access | Times Cited: 5
Cancer nanotheranostics in the second near‐infrared window
Shanshan Jiang, Kai Huang, Junle Qu, et al.
View (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 35
Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells
А. В. Степанов, Jia Xie, Qiaoqiao Zhu, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 5, pp. 529-543
Closed Access | Times Cited: 12
CAR-T Cell Therapy for Solid Tumors
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access
Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors
Hinrich Abken
Human Gene Therapy (2021) Vol. 32, Iss. 19-20, pp. 1011-1028
Open Access | Times Cited: 21
Light‐Controllable Binary Switch Activation of CAR T Cells
Aya Kobayashi, Alberto Nobili, Steven C. Neier, et al.
ChemMedChem (2022) Vol. 17, Iss. 12
Open Access | Times Cited: 13
Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies
Haobing Wang, Ling Tang, Yingjie Kong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9115-9115
Open Access | Times Cited: 8
Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signalling
Nickolas Serniuck, Eden Kapcan, Duane Moogk, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200842-200842
Open Access | Times Cited: 2
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells**
Wenyue Cao, Zhi Geng, Na Wang, et al.
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 10
Open Access | Times Cited: 14
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
Caili Xu, Dianwen Ju, Xuyao Zhang
Antibody Therapeutics (2022) Vol. 5, Iss. 1, pp. 73-83
Open Access | Times Cited: 10
Application and Design of Switches Used in CAR
Paweł Głowacki, Piotr Rieske
Cells (2022) Vol. 11, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 8
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules
Omozojie P. Aigbogun, Christopher P. Phenix, Ed S. Krol, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 853-874
Closed Access | Times Cited: 4
Intelligent cell-based therapies for cancer and autoimmune disorders
Rui Chen, Jing Ji, Stefan Siwko, et al.
Current Opinion in Biotechnology (2020) Vol. 66, pp. 207-216
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top